Yudong Wu

Pyrotinib plus capecitabine versus lapatinib plus capecitabine for the treatment of HER2-positive metastatic breast cancer (PHOEBE): a multicentre, open-label, randomised, controlled, phase 3 trial

Binghe Xu, Min Yan, Fei Ma et al. · The Lancet Oncology · 2021 · 372 citations

Capecitabine Versus Lapatinib, Breast Oncology, Medicine +8

Crucial biological functions of CCL7 in cancer

Yangyang Liu, Yadi Cai, Li Liu et al. · PeerJ · 2018 · 127 citations · Full text

Cc Chemokine, Immunology, Cell Death +17

Enhanced Fluorescence ELISA Based on HAT Triggering Fluorescence “Turn-on” with Enzyme–Antibody Dual Labeled AuNP Probes for Ultrasensitive Detection of AFP and HBsAg

Yudong Wu, Weisheng Guo, Weipan Peng et al. · ACS Applied Materials & Interfaces · 2017 · 101 citations

Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial

Zefei Jiang, Quchang Ouyang, Tao Sun et al. · Nature Medicine · 2024 · 90 citations

Breast Oncology, Medicine, Pharmacology +6

Cancer-associated adipocyte-derived G-CSF promotes breast cancer malignancy via Stat3 signaling

Li Liu, Yudong Wu, Cheng Zhang et al. · Journal of Molecular Cell Biology · 2020 · 67 citations · Full text

Cancer Research, Breast Oncology, Signaling Pathway +15